Home > Insider Trading > United Therapeutics Corp

United Therapeutics Corp (UTHR)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
71 - 80
Next >>

Era Group Inc (ERA), BioMarin Pharmaceutical Inc. (BMRN), & Assured Guaranty Ltd. (AGO) Among Stocks Amici Capital Is Bullish on

Paul Orlin's Amici Capital has increased its exposure to Era Group Inc (NYSE:ERA), as a new filing with the Securities and Exchange Commission shows.

Keep Reading →

March 27th, 2015 - Hedge Funds News

Palo Alto Rejoicing at ABIOMED, Inc. (ABMD)'s 18% Spike

ABIOMED, Inc. (NASDAQ:ABMD) spiked as high as 21% in Tuesday's intraday trading to eventually close at 18% in the green at $72.48.

Keep Reading →

March 25th, 2015 - Hedge Funds Market Movers News

Akorn, Inc. (AKRX), United Therapeutics Corporation (UTHR) Among Consonance Capital's Winning Bets in Healthcare

The $5.50 billion pharmaceutical company Akorn, Inc. (NASDAQ:AKRX) was one of the top gainers on Wednesday, closing the session with an almost 10% gain.

Keep Reading →

March 19th, 2015 - Hedge Funds News

Amicus Therapeutics Inc. (FOLD): Palo Alto Investors Sells Half of its Stake At Sky-High Valuation

William Leland Edwards’ Palo Alto Investors disclosed today a 50% decrease in its exposure to Amicus Therapeutics, Inc. (NASDAQ:FOLD).

Keep Reading →

October 8th, 2014 - Hedge Funds News

InterMune Inc (ITMN), United Therapeutics Corporation (UTHR), Cyberonics Inc. (CYBX): Palo Alto Investors Loves Healthcare Stocks

Palo Alto Investors is a hedge fund founded by William Leland Edwards in 1989, and managed by him ever since.

Keep Reading →

September 9th, 2014 - Hedge Funds News

Consonance Capital Management is Fond of Healthcare Stocks

Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD.

Keep Reading →

May 27th, 2014 - Hedge Funds News

Joel Greenblatt's Top Picks Include United Therapeutics and Activision Blizzard

One of the funds we track is Joel Greenblatt's Gotham Asset Management, which recently filed its 13F form, disclosing its equity portfolio as at the end of the third quarter of the year.

Keep Reading →

November 15th, 2013 - Hedge Funds News

Hedge Funds Are Dumping Dr. Reddy's Laboratories Limited (ADR) (RDY)

To many of your fellow Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY) investors, hedge funds are perceived as overrated, outdated investment vehicles of an era lost to time.

Keep Reading →

September 11th, 2013 - News